Johannes B Roedl

Summary

Publications

  1. ncbi Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions
    Johannes B Roedl
    Division of Abdominal and Interventional Radiology, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
    AJR Am J Roentgenol 191:515-21. 2008
  2. ncbi Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer
    Johannes B Roedl
    Division of Abdominal and Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    Eur Radiol 18:2833-40. 2008
  3. ncbi Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus
    Johannes B Roedl
    Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    Mol Imaging Biol 11:54-60. 2009
  4. ncbi Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography
    Johannes B Roedl
    Division of Abdominal and Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Ann Thorac Surg 86:1131-8. 2008
  5. ncbi Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters
    Johannes B Roedl
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Abdom Imaging 34:610-7. 2009
  6. ncbi Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements
    Johannes B Roedl
    Department of Radiology, Division of Abdominal and Interventional Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Acad Radiol 16:218-26. 2009
  7. ncbi Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation
    Johannes B Roedl
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Radiother Oncol 89:278-86. 2008

Detail Information

Publications7

  1. ncbi Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions
    Johannes B Roedl
    Division of Abdominal and Interventional Radiology, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
    AJR Am J Roentgenol 191:515-21. 2008
    ..The purpose of our study was to evaluate a visual PET/CT scoring system for the differentiation of benign and early malignant esophageal uptake...
  2. ncbi Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer
    Johannes B Roedl
    Division of Abdominal and Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    Eur Radiol 18:2833-40. 2008
    ..Tumour length measured with PET-CT or PET is associated with stage and overall survival of oesophageal cancer and helps to guide the appropriate treatment approach...
  3. ncbi Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus
    Johannes B Roedl
    Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    Mol Imaging Biol 11:54-60. 2009
    ..Furthermore, the "diameter-SUV index" was calculated by multiplying the tumor diameter by the mean SUV...
  4. ncbi Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography
    Johannes B Roedl
    Division of Abdominal and Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Ann Thorac Surg 86:1131-8. 2008
    ....
  5. ncbi Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters
    Johannes B Roedl
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Abdom Imaging 34:610-7. 2009
    ..In order to investigate the value of FDG positron emission tomography-computed tomography (PET-CT), FDG PET (reviewed side-by-side with CT), and metabolic parameters in the assessment of lymph node status and prognosis...
  6. ncbi Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements
    Johannes B Roedl
    Department of Radiology, Division of Abdominal and Interventional Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Acad Radiol 16:218-26. 2009
    ..To investigate the accuracy of M staging (staging of metastatic disease) in esophageal carcinoma based on a visual interpretation and based on tumor volume measurements on positron emission tomography (PET) computed tomography (CT)...
  7. ncbi Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation
    Johannes B Roedl
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Radiother Oncol 89:278-86. 2008
    ....